Molly Thomas
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Pharmacology top 5%
Papers in
-
- Plant biochemistry and biosynthesis 6
- Oncology 9
- Cancer Immunotherapy and Biomarkers 8
- Neutropenia and Cancer Infections 3
- CAR-T cell therapy research 3
- Co-authors
- Francis Gricilda Shoba (2 shared papers)K. Mark Ansel (5 shared papers)Joshua Babiarz (4 shared papers)Robert Blelloch (2 shared papers)Christopher D.C. Allen (1 shared paper)David Steiner (1 shared paper)Joyce Hu (1 shared paper)Zhiyong Yang (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Transplantation (2 papers)Medicine & Science in Sports & Exercise (1 paper)BMJ Open (1 paper)Blood (1 paper)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Molly Thomas
45 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 319
- Pharmacology 127
- Applied Microbiology and Biotechnology 24
- Complementary and alternative medicine 96
- Immunology 209
Countries citing papers authored by Molly Thomas
This map shows the geographic impact of Molly Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly Thomas more than expected).
Fields of papers citing papers by Molly Thomas
This network shows the impact of papers produced by Molly Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly Thomas. The network helps show where Molly Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Molly Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 332 | |
| 2 | 2011 | 299 | |
| 3 | 1964 | 163 | |
| 4 | 2015 | 99 | |
| 5 | 2011 | 97 | |
| 6 | 2018 | 78 | |
| 7 | 1994 | 67 | |
| 8 | 2012 | 56 | |
| 9 | 1996 | 34 | |
| 10 | 2005 | 27 | |
| 11 | 2014 | 26 | |
| 12 | 2010 | 25 | |
| 13 | 1988 | 25 | |
| 14 | 1983 | 24 | |
| 15 | 2020 | 19 | |
| 16 | 1999 | 15 | |
| 17 | 2018 | 13 | |
| 18 | 2015 | 11 | |
| 19 | 1991 | 11 | |
| 20 | 2010 | 9 |
About Molly Thomas
Molly Thomas is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Plant Science, having authored 49 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Plant biochemistry and biosynthesis (6 papers), MicroRNA in disease regulation (6 papers), Immune Cell Function and Interaction (4 papers), Biodiesel Production and Applications (3 papers), Neutropenia and Cancer Infections (3 papers), CAR-T cell therapy research (3 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). The work is most often cited by research in Cancer Research (319 citations), Pharmacology (127 citations), Applied Microbiology and Biotechnology (24 citations), Complementary and alternative medicine (96 citations) and Immunology (209 citations). Molly Thomas has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Francis Gricilda Shoba, K. Mark Ansel, Joshua Babiarz, Robert Blelloch, Christopher D.C. Allen, David Steiner, Joyce Hu, Zhiyong Yang, Emmanuel Farber and Benito Lombardi. Their work appears in journals such as Journal of Clinical Oncology, Transplantation, Medicine & Science in Sports & Exercise, BMJ Open and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.